Assignee profile:

GW Pharma Limited

City:

Salisbury

Country:

United Kingdom

Published Applications:

53

Last publication date:

2019-04-04

Patent Grants:

32

Last grant date:

2020-09-01

Top Inventors for applications by GW Pharma Limited

These are the the leading inventors for applications assigned to GW Pharma Limited:

Recent patent applications by GW Pharma Limited

GW Pharma Limited based in Salisbury, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2019-04-04
US20190099492A1
Human necessities

CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS

#2 | 2019-04-04 ✅ Patent 10,758,514 granted on 2020-09-01
US20190099398A1
Human necessities

Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumour

#3 | 2017-03-23
US20170079933A1
Human necessities

COMPOSITIONS COMPRISING CANNABINOIDS FOR TREATMENT OF NAUSEA, VOMITING, EMESIS, MOTION SICKNESS OR LIKE CONDITIONS

#4 | 2016-12-15
US20160361290A1
Human necessities

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASE AND/OR SYMPTOMS IN ARTHRITIS

#5 | 2016-12-15
US20160360721A1
Human necessities

CANNABIS SATIVA PLANTS RICH IN CANNABICHROMENE AND ITS ACID, EXTRACTS THEREOF AND METHODS OF OBTAINING EXTRACTS THEREFROM

#6 | 2016-01-21
US20160015682A2
Human necessities

TETRAHYDROCANNABIVARIN (THCV) FOR USE IN THE PROTECTION OF PANCREATIC ISLET CELLS

#7 | 2015-12-17 ✅ Patent 9,474,726 granted on 2016-10-25
US20150359755A1
Human necessities

Use of cannabinoids in the treatment of epilepsy

#8 | 2015-11-26 ✅ Patent 9,522,123 granted on 2016-12-20
US20150335590A1
Human necessities

Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy

#9 | 2015-11-19 ✅ Patent 10,220,005 granted on 2019-03-05
US20150328171A2
Human necessities

Synergistic therapies of cannabidiol with hypothermia for neuroprotection

#10 | 2015-03-26 ✅ Patent 9,675,654 granted on 2017-06-13
US20150086653A1
Human necessities

Phytocannabinoids in the treatment of cancer

#11 | 2014-12-25
US20140378539A9
Human necessities

CANNABINOIDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN

#12 | 2014-12-25 ✅ Patent 9,205,063 granted on 2015-12-08
US20140377382A1
Human necessities

Cannabinoid-containing plant extracts as neuroprotective agents

#13 | 2014-10-02 ✅ Patent 9,029,423 granted on 2015-05-12
US20140296351A1
Human necessities

Pharmaceutical formulation

#14 | 2014-09-25
US20140287067A1
Human necessities

ANTI-TUMOURAL EFFECTS OF CANNABINOID COMBINATIONS

#15 | 2014-06-05
US20140155456A9
Human necessities

USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY

#16 | 2014-04-17 ✅ Patent 9,895,342 granted on 2018-02-20
US20140107192A1
Human necessities

Cannabinoids for use in the treatment of neuropathic pain

#17 | 2013-11-07
US20130296398A1
Human necessities

USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY

#18 | 2013-09-19
US20130245110A1
Human necessities

USE FOR CANNABINOIDS

#19 | 2013-09-19
US20130245109A9
Human necessities

PHARMACEUTICAL FORMULATION

#20 | 2013-05-02 ✅ Patent 8,603,515 granted on 2013-12-10
US20130109747A1
Human necessities

Pharmaceutical formulation

#21 | 2013-03-07 ✅ Patent 8,790,719 granted on 2014-07-29
US20130059018A1
Human necessities

Phytocannabinoids in the treatment of cancer

#22 | 2013-01-03 ✅ Patent 8,512,767 granted on 2013-08-20
US20130006182A1
Human necessities

Pharmaceutical compositions

#23 | 2012-12-27 ✅ Patent 8,481,091 granted on 2013-07-09
US20120328718A1
Human necessities

Pharmaceutical compositions

#24 | 2012-09-27
US20120245224A1
Human necessities

CANNABINOIDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN

#25 | 2012-09-06
US20120225136A1
Human necessities

INHIBITION OF TUMOUR CELL MIGRATION

#26 | 2012-06-28 ✅ Patent 9,066,920 granted on 2015-06-30
US20120165402A1
Human necessities

Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy

#27 | 2012-03-08
US20120059062A1
Human necessities

COMPOSITIONS COMPRISING CANNABINOIDS FOR TREATMENT OF NAUSEA, VOMITING, EMESIS, MOTION SICKNESS OR LIKE CONDITIONS

#28 | 2012-01-05 ✅ Patent 9,125,859 granted on 2015-09-08
US20120004251A1
Human necessities

Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy

#29 | 2011-09-22 ✅ Patent 8,771,760 granted on 2014-07-08
US20110230549A1
Human necessities

Method for the treatment of constipation

#30 | 2011-05-19 ✅ Patent 8,632,825 granted on 2014-01-21
US20110117216A1
Human necessities

Anti-tumoural effects of cannabinoid combinations

#31 | 2011-04-07
US20110082195A1
Human necessities

NEW USE FOR CANNABINOIDS

#32 | 2011-02-17 ✅ Patent 9,017,737 granted on 2015-04-28
US20110038958A1
Human necessities

Use of cannabinoids in combination with an anti-psychotic medicament

#33 | 2010-12-23
US20100323038A1
Human necessities

Pharmaceutical Compositions

#34 | 2010-09-23 ✅ Patent 8,673,368 granted on 2014-03-18
US20100239693A1
Human necessities

Cannabinoid-containing plant extracts as neuroprotective agents

#35 | 2010-08-05 ✅ Patent 8,211,946 granted on 2012-07-03
US20100196488A1
Performing operations; transporting

Pharmaceutical formulation

#36 | 2010-07-01 ✅ Patent 8,846,409 granted on 2014-09-30
US20100168448A1
Performing operations; transporting

Methods of preparing cannabinoids from plant material

#37 | 2010-05-13 ✅ Patent 9,034,395 granted on 2015-05-19
US20100119606A1
Human necessities

Processes and apparatus for extraction of active substances and enriched extracts from natural products

#38 | 2009-11-05 ✅ Patent 8,061,351 granted on 2011-11-22
US20090276090A1
Human necessities

Dose dispensing system and apparatus

#39 | 2009-02-05 ✅ Patent 9,035,130 granted on 2015-05-19
US20090035396A1
Human necessities

Reference plant, a method for its production, extracts obtained therefrom and their use

#40 | 2008-07-10
US20080167483A1
Human necessities

EXTRACTION OF PHARMACEUTICALLY ACTIVE COMPONENTS FROM PLANT MATERIALS

#41 | 2008-05-22 ✅ Patent 9,168,278 granted on 2015-10-27
US20080119544A1
Human necessities

Use for cannabinoid

#42 | 2008-03-20
US20080071233A1
Human necessities

Pharmaceutical compositions

#43 | 2008-03-18 ✅ Patent 7,344,736 granted on 2008-03-18
US10218972
-

Extraction of pharmaceutically active components from plant materials

#44 | 2008-02-07 ✅ Patent 8,481,085 granted on 2013-07-09
US20080031977A1
Human necessities

Pharmaceutical compositions comprising cannabigerol

#45 | 2006-12-14
US20060282300A1
Physics

System for influencing and monitoring the movement of products

#46 | 2006-11-23
US20060261084A1
Human necessities

Dose dispensing apparatus

#47 | 2006-11-02 ✅ Patent 7,968,594 granted on 2011-06-28
US20060247304A1
Human necessities

Pharmaceutical compositions for the treatment of pain

#48 | 2006-07-13 ✅ Patent 8,470,874 granted on 2013-06-25
US20060153941A1
Human necessities

Pharmaceutical compositions comprising cannabichromene type compounds

#49 | 2006-06-22
US20060135599A1
Human necessities

Use for pharmaceutical composition

#50 | 2006-03-30 ✅ Patent 7,709,536 granted on 2010-05-04
US20060068034A1
Performing operations; transporting

Pharmaceutical formulation

#51 | 2005-12-01 ✅ Patent 7,700,368 granted on 2010-04-20
US20050266108A1
Performing operations; transporting

Methods of purifying cannabinoids from plant material

#52 | 2005-08-16 ✅ Patent 6,929,154 granted on 2005-08-16
US10399573
-

Secure dispensing apparatus

#53 | 2005-07-14 ✅ Patent 7,537,005 granted on 2009-05-26
US20050150488A1
Human necessities

Dose dispensing system and apparatus

Also check out GW Pharma Limited's (Salisbury, United Kingdom) applicant profile with 9 patent applications submitted.

AssigneeID:

2129 ⎘